salmeterol xinafoate






469 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1346793 Salmeterol, a new inhaled beta 2-adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction. J Allergy Clin Immunol 1992 Feb 1
2 1346794 A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity, and increase in urinary leukotriene E4 excretion. J Allergy Clin Immunol 1992 Feb 2
3 1346963 Risks versus benefits of inhaled beta 2-agonists in the management of asthma. Drug Saf 1992 Jan-Feb 1
4 1350364 [Salmeterol and prolonged treatment of asthma: international clinical data]. Rev Mal Respir 1992 1
5 1350370 [Pharmacological properties of salmeterol]. Rev Mal Respir 1992 2
6 1354536 Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br J Pharmacol 1992 Apr 1
7 1355645 Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Child 1992 Aug 1
8 1357550 Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992 Oct 22 1
9 1357554 A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992 Nov 12 2
10 1358381 The effects of beta 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes. Br J Pharmacol 1992 Sep 1
11 1358932 Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma. J Allergy Clin Immunol 1992 Nov 1
12 1359777 Salmeterol xinafoate: a review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease. Allergol Immunopathol (Madr) 1992 Mar-Apr 2
13 1360657 Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro. Pharmacol Toxicol 1992 Oct 1
14 1360770 Onset of action and duration of effect of formoterol and salmeterol compared to salbutamol in isolated guinea pig trachea with or without epithelium. Allergy 1992 Aug 1
15 1361068 Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms). Respir Med 1992 Sep 4
16 1361250 Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor. Thorax 1992 Nov 4
17 1675178 Long-acting beta 2-adrenoceptor agonists: a new perspective in the treatment of asthma. Eur Respir J 1991 Feb 1
18 1683037 [Treatment of asthma with salmeterol--a new prolonged-action inhalatory beta 2 agonist]. Ugeskr Laeger 1991 Oct 28 1
19 1686530 Salmeterol: a novel drug for the treatment of asthma. Agents Actions Suppl 1991 1
20 1686740 Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol 1991 Nov 4
21 1687131 Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease. Eur Respir J 1991 Nov 2
22 1687365 Estimation of the efficacy and affinity of the beta 2-adrenoceptor agonist salmeterol in guinea-pig trachea. Br J Pharmacol 1991 Dec 2
23 1723379 Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease. Drugs 1991 Nov 2
24 1974667 Approaches to a long-acting, selective beta 2-adrenoceptor stimulant. Lung 1990 1
25 1974668 The pharmacology of salmeterol. Lung 1990 1
26 1974680 Long-term studies on long-acting sympathomimetics. Lung 1990 1
27 1975162 Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. Am Rev Respir Dis 1990 Sep 2
28 1980220 Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. BMJ 1990 Dec 15 1
29 2904183 Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 1988 Sep 2
30 7521712 Influence of salmeterol, a long-acting beta 2-adrenoceptor agonist, on IgE-mediated histamine release from human basophils. J Investig Allergol Clin Immunol 1994 Jan-Feb 6
31 7541622 The effects of long-term treatment with salmeterol and salbutamol on the flow rate and composition of whole saliva in the rat. Arch Oral Biol 1995 Mar 1
32 7552578 Inhibition of some aspects of acute inflammation of guinea-pig lung by intraperitoneal dexamethasone and mifepristone: demonstration of agonist activity of mifepristone in the guinea-pig. Inflamm Res 1995 Mar 1
33 7552926 Safety of salmeterol in the maintenance treatment of asthma. Ann Allergy Asthma Immunol 1995 Sep 1
34 7616798 Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet 1995 Jul 22 1
35 7648384 Pharmacology of long-acting beta-agonists. Ann Allergy Asthma Immunol 1995 Aug 2
36 7648385 Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy. Ann Allergy Asthma Immunol 1995 Aug 1
37 7713162 Anti-inflammatory effects of a short-acting and a long-acting beta 2-adrenoceptor agonist in guinea pig skin. Eur J Pharmacol 1995 Jan 16 1
38 7752089 Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterol. J Pharmacol Exp Ther 1995 May 2
39 7768283 Beta 2-adrenoceptors mediate a reduction in endothelial permeability in vitro. Eur J Pharmacol 1995 Feb 14 1
40 7780648 Effects of beta 2-adrenoceptor agonists on anti-IgE-induced contraction and smooth muscle reactivity in human airways. Br J Pharmacol 1995 Mar 1
41 7858856 The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro. Br J Pharmacol 1994 Nov 3
42 7882570 Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clin Exp Immunol 1995 Mar 5
43 7902176 Salmeterol, a long-acting beta 2-adrenoceptor agonist mediating cyclic AMP accumulation in a neuronal cell line. Br J Pharmacol 1993 Oct 3
44 7905340 Effects of beta-adrenoceptor agonists in human bronchial smooth muscle. Br J Pharmacol 1993 Nov 1
45 7905757 Salmeterol: a novel, long-acting beta 2-agonist. Ann Pharmacother 1993 Dec 4
46 7909285 A 1-week dose-ranging study of inhaled salmeterol in patients with asthma. Chest 1994 Apr 1
47 7909853 Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA 1994 May 11 1
48 7912202 Why are long-acting beta-adrenoceptor agonists long-acting? Eur Respir J 1994 Mar 2
49 7914175 Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic. Eur Respir J 1994 May 2
50 7915501 Salmeterol compared with slow-release terbutaline in nocturnal asthma. A multicenter, randomized, double-blind, double-dummy, sequential clinical trial. French Multicenter Study Group. Allergy 1994 Jul 2